Six studies defined T2DM as abnormal laboratory tests (HbA1c or fasting blood glucose), self-reported physician-diagnosed diabetes, or use of oral hypoglycemic medications or insulin [18,20,21,22,24,25]. This evidence concerns the gene INS and diabetes mellitus.